Update On…

Update on … Non-Small Cell Lung Cancer

Susan Weiss Behrend

non-small cell lung, non-small-cell lung, cancer treatment, chemotherapy
ONF 2013, 40(5), 519-520. DOI: 10.1188/13.ONF.519-520

A study by Groth et al. (2013) identified the impact of insurance status on the delivery of definitive lobectomy for early-stage non-small cell lung cancer (NSCLC). One-fifth of an estimated 226,000 cases in 2012 presented with early-stage disease (Siegel, Naishadham, & Jemal, 2012). With appropriate therapy, five-year survival rates can exceed 65%, whereas, without prompt and aggressive intervention, five-year survival plummets to less than 5% (National Cancer Institute, 2010). Healthcare providers must offer access and optimal treatment to this patient population regardless of insurance status.

Jump to a section


    Groth, S. S., Al-Refaie, W. B., Zhong, W., Vickers, S. M., Maddaus, M. A., D'Cunha, J., & Habermann, E. B. (2013). Effect of insurance status on the surgical treatment of early-stage non-small cell lung cancer. Annals of Thoracic Surgery, 95, 1221-1226. doi:10.1016/j.athroracsur.2012.10.079
    National Cancer Institute. (2010). Surveillance, Epidemiology, and End Results (SEER) surveillance research program. Retrieved from http://seer.cancer.gov
    Siegel, R., Naishadham, D., & Jemal, A. (2012). Cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 62, 10-29. doi:10.3322/caac.20138
    Burger, R. A., Brady, M. F., Bookman, M. A., Fleming, G. F., Monk, B. J., Huang, H., … Liang, S. X. (2011). Incorporation of bevacizumab in the primary treatment of ovarian cancer. New England Journal of Medicine, 365, 2473-2483. doi:10.1056/NEJMoa1104390
    Childhood ALL Collaborative Group. (1996). Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: Overview of 42 trials involving 12,000 randomised children. Lancet, 347, 1783-1788. doi:10.1016/S0140-6736(96)91615-3
    Gerber, D. E., & Schiller, J. H. (2013). Maintenance chemotherapy for advanced non-small-cell lung cancer: New life for an old idea. Journal of Clinical Oncology, 31, 1009-1020. doi:10:1200/JCO.2012.43.7459
    Giuliani, F., De Vita, F., Colucci, G., & Pisconti, S. (2010). Maintenance therapy in colon cancer. Cancer Treatment Review, 36(Suppl. 3), S42-S45. doi:10.1016/S0305-7372(10)70019-0
    Lima, J. P. S. N., dos Santos, L. V., Sasse, E. C., & Sasse, A. D. (2009). Optimal duration of first-line chemotherapy for advanced non-small cell lung cancer: A systematic review with meta-analysis. European Journal of Cancer, 45, 601-607. doi:10.1016/j.ejca.2008.11.006